InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Streck Paul. Insider active across 2 companies, notably Albireo Pharma, INC.. Cumulatively, 7 filings have been recorded. Split: 1 buy · 1 sell. Total volume traded: €19k. History available since 19 December 2022. The latest transaction was filed on 4 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
STRECK PAUL is a declarant linked to Albireo Pharma, INC. and PepGen Inc., where he is listed as Chief Medical Officer and EVP, Head of R&D. The record shows 4 filings in total, all within the recent sample, with Attribution transactions between 2022-12-21 and 2025-03-05, and buy and sell amounts of EUR 0.